251 related articles for article (PubMed ID: 15570747)
1. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II).
Chandran P; Satthaporn S; Robins A; Eremin O
Surgeon; 2003 Jun; 1(3):125-36. PubMed ID: 15570747
[TBL] [Abstract][Full Text] [Related]
2. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
3. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
Schultz M; Schölmerich J; Rath HC
Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
[TBL] [Abstract][Full Text] [Related]
4. Microbiota and mucosal defense in IBD: an update.
Stange EF; Schroeder BO
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
[No Abstract] [Full Text] [Related]
5. The gut microbiota in inflammatory bowel disease.
Macfarlane GT; Blackett KL; Nakayama T; Steed H; Macfarlane S
Curr Pharm Des; 2009; 15(13):1528-36. PubMed ID: 19442170
[TBL] [Abstract][Full Text] [Related]
6. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
Merga Y; Campbell BJ; Rhodes JM
Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
[TBL] [Abstract][Full Text] [Related]
7. Probiotics and inflammatory bowel disease: is there a scientific rationale?
Shanahan F
Inflamm Bowel Dis; 2000 May; 6(2):107-15. PubMed ID: 10833070
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I).
Chandran P; Satthaporn S; Robins A; Eremin O
Surgeon; 2003 Apr; 1(2):63-75. PubMed ID: 15573623
[TBL] [Abstract][Full Text] [Related]
9. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
[TBL] [Abstract][Full Text] [Related]
10. The Intestinal Microbiota in Inflammatory Bowel Disease.
Becker C; Neurath MF; Wirtz S
ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
[TBL] [Abstract][Full Text] [Related]
11. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.
Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I
Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088
[TBL] [Abstract][Full Text] [Related]
12. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
13. From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?
Tomasello G; Bellavia M; Palumbo VD; Gioviale MC; Damiani P; Lo Monte AI
Ann Ital Chir; 2011; 82(5):361-8. PubMed ID: 21988043
[TBL] [Abstract][Full Text] [Related]
14. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
Sartor RB
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
[TBL] [Abstract][Full Text] [Related]
15. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Conte MP; Schippa S; Zamboni I; Penta M; Chiarini F; Seganti L; Osborn J; Falconieri P; Borrelli O; Cucchiara S
Gut; 2006 Dec; 55(12):1760-7. PubMed ID: 16648155
[TBL] [Abstract][Full Text] [Related]
16. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease.
Famularo G; Mosca L; Minisola G; Trinchieri V; De Simone C
Curr Pharm Des; 2003; 9(24):1973-80. PubMed ID: 12871183
[TBL] [Abstract][Full Text] [Related]
17. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
Duchmann R; Lochs H; Kruis W
MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
[TBL] [Abstract][Full Text] [Related]
18. Resident bacterial flora and immune system.
Biancone L; Monteleone I; Del Vecchio Blanco G; Vavassori P; Pallone F
Dig Liver Dis; 2002 Sep; 34 Suppl 2():S37-43. PubMed ID: 12408438
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of probiotics in inflammatory bowel diseases.
Mach T
J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
[TBL] [Abstract][Full Text] [Related]
20. Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases.
Scarpato E; Russo M; Staiano A
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S7-S9. PubMed ID: 30036240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
